Noel Tulipan Archives
VUMC mourns loss of Pediatric Neurosurgery pioneer Tulipan
Nov. 5, 2015—Noel Tulipan, M.D., renowned neurosurgeon and trailblazer in fetal surgery repair for spina bifida, died Monday after a long illness. He was 64.
Tulipan’s career as ‘humble’ giant of Neurosurgery honored
Jun. 11, 2015—Noel Tulipan, M.D., has left an indelible mark on many facets of life during his pioneering career at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt — from his impact on the field of neurosurgery and fetal surgery repair; to the children and families he cared for; to the residents he trained; to the operating room team he scrubbed in alongside; to his many friends and colleagues.
Baby’s life-changing surgery, before birth
Jul. 18, 2013—Vanderbilt’s Junior League Fetal Center is offering ground-breaking treatments and surgeries in the hopes of providing unborn babies the best start to life. Vanderbilt’s Barb Cramer has the amazing story– and surgical video– of fetal surgery to repair an unborn baby’s spinal cord defect. For more about Vanderbilt’s Fetal Center, go to: http://childrenshospital.vanderbilt.org
Teamwork drives Maternal Fetal Medicine program
Jul. 18, 2013—When Steffanie and Jon Sawyer were told their unborn son had a spinal birth defect called spina bifida, they decided to travel from their home in the Chicago area to Vanderbilt for fetal surgery.
VUCast: Life-changing surgery before birth – through mom’s womb!
Jul. 17, 2013—In this week’s VUCast: See a baby’s life-changing surgery before he’s even born! A former senator and Vandy grad shares important pieces of history. See a hot weather homerun All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now.
Walk to benefit hydrocephalus set for July 28
Jul. 19, 2012—Nashville will have a first-ever walk for hydrocephalus Saturday, July 28, raising awareness and support for research.
Vanderbilt-pioneered fetal surgery procedure yields positive results
Feb. 9, 2011—Results of a landmark, seven-year National Institutes of Health-funded trial, Management of Myelomeningocele Study (MOMS), demonstrate clear benefit for babies who undergo fetal surgery to treat spina bifida, the most common birth defect in the central nervous system.